View of Design and validation of a robust RP-UPLC approach for simultaneous quantification of emtricitabine, tenofovir, and nelfinavir in active pharmaceutical ingredients and finished dosage products

Return to Article Details Design and validation of a robust RP-UPLC approach for simultaneous quantification of emtricitabine, tenofovir, and nelfinavir in active pharmaceutical ingredients and finished dosage products Download Download PDF